Skip to main content
All lobbying clients

AMNEAL PHARMACEUTICALS

Lobbying client · New Jersey · filed 2025 to 2026

Pharmaceutical company

$2,920,000 Reported spend
22 Filings counted
2 Outside firms hired
2 Bills named

Spend is reported income plus in-house expenses across 22 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 3 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as AMNEAL PHARMACEUTICALS LLC, AMNEAL PHARMACEUTICALS, INC.

 Who filed for this client 3

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 2
  • H.R. 5304
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
    1 filing
  • S. 2587
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
    1 filing
 Reported by year 2 years
  • 2026 $830,000 9 filings
  • 2025 $2,090,000 13 filings
 Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 3
  • HOUSE OF REPRESENTATIVES 21
  • SENATE 21
  • White House Office 7
 Recent filings 22 total
Q3 report
AMNEAL PHARMACEUTICALS
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $210,000 expenses · posted Oct 20, 2026
View → Q3 report
TARPLIN, DOWNS & YOUNG, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View → Q3 report
OGR
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 17, 2026
View → Q2 report
AMNEAL PHARMACEUTICALS
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $190,000 expenses · posted Jul 20, 2026
View → Q2 report
OGR
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 17, 2026
View → Q2 report
TARPLIN, DOWNS & YOUNG, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 16, 2026
View → Q1 report
AMNEAL PHARMACEUTICALS
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $190,000 expenses · posted Apr 20, 2026
View → Q1 report
TARPLIN, DOWNS & YOUNG, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 20, 2026
View → Q1 report
OGR
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $20,000 income · posted Apr 19, 2026
View → Q4 report
TARPLIN, DOWNS & YOUNG, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 20, 2026
View → Q4 report
AMNEAL PHARMACEUTICALS
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $340,000 expenses · posted Jan 20, 2026
View → Q4 report
OGR
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $20,000 income · posted Jan 17, 2026
View → Q3 report
AMNEAL PHARMACEUTICALS
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $310,000 expenses · posted Oct 20, 2025
View → Q3 report
OGR
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 19, 2025
View → Q3 report
TARPLIN, DOWNS & YOUNG, LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 16, 2025
View → Q2 report
AMNEAL PHARMACEUTICALS
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $210,000 expenses · posted Jul 21, 2025
View → Q2 report
OGR
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 19, 2025
View → Q2 report
TARPLIN, DOWNS & YOUNG, LLC
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 16, 2025
View → Q1 report
AMNEAL PHARMACEUTICALS
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $910,000 expenses · posted Apr 21, 2025
View → Q1 report
OGR
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $20,000 income · posted Apr 21, 2025
View →

Showing the 20 most recent of 22 filings. Search the explorer for "AMNEAL PHARMACEUTICALS".

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem